Allergic diseases and asthma in relation to serum immunoglobulins and salivary immunoglobulin A in pre-school children: a follow-up community-based study
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2005
Metadata
Show full item recordCitation
Clin. Exp. Allergy 2005, 35(1):64-9Abstract
BACKGROUND: We have previously reported an association between low IgA and allergic manifestations in early childhood (0-2 years) and have now followed our cohort for an additional 2 years. OBJECTIVE: To evaluate in a longitudinal community-based cohort study the association between maturation of Ig production and allergic manifestations in the first 4 years of life. METHODS: A cohort of 161 randomly selected children was followed from birth to the age of 42-48 months and evaluated at 18-23 months (EV1; n = 179) and again at the age of 42-48 months (EV2; n = 161). Diagnoses were made with the help of a clinical questionnaire, physical examination and skin prick tests (SPTs) to 10 common allergens. Serum immunoglobulins were measured at EV1 and EV2, and salivary IgA (sal-IgA) at EV2. RESULTS: Serum IgA, IgE, IgG1, IgG2 and IgG4 increased from 2 to 4 years of age (P < 0.001) and their levels showed close correlations (P < or = 0.01 for most comparisons). Children with one or more positive SPTs had lower serum IgA (P = 0.004) and IgG4 (P = 0.05) at EV2 than those who did not respond, and children who developed allergic rhinitis between EV1 and EV2 had low sal-IgA (P = 0.006) and IgG3 (P < 0.05) at EV2. Atopic eczema was associated with low sal-IgA at EV2, and children who developed eczema between EV1 and EV2 had significantly lower sal-IgA than those who recovered after EV1 (P = 0.02). CONCLUSION: Allergic manifestations in predisposed children may be influenced by the rate of maturation of immunological components that counteract sensitization or inhibit effector mechanisms of allergy.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Link fieldae974a485f413a2113503eed53cd6c53
10.1111/j.1365-2222.2005.02141.x
Scopus Count
Collections
Related articles
- Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis.
- Authors: Lowe AJ, Hosking CS, Bennett CM, Carlin JB, Abramson MJ, Hill DJ, Dharmage SC
- Issue date: 2007 Nov
- Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
- Authors: Kihlström A, Hedlin G, Pershagen G, Troye-Blomberg M, Härfast B, Lilja G
- Issue date: 2005 Dec
- Early predictors for developing allergic disease and asthma: examining separate steps in the 'allergic march'.
- Authors: Almqvist C, Li Q, Britton WJ, Kemp AS, Xuan W, Tovey ER, Marks GB, CAPS team.
- Issue date: 2007 Sep
- Ovalbumin-specific immunoglobulins A and G levels at age 2 years are associated with the occurrence of atopic disorders.
- Authors: Kukkonen AK, Savilahti EM, Haahtela T, Savilahti E, Kuitunen M
- Issue date: 2011 Oct
- Comparison of Der p1-specific antibody levels in children with allergic airway disease and healthy controls.
- Authors: Aydogan M, Mete N, Yazi D, Akkoc T, Ozdemir C, Blaser K, Akdis M, Akdis C, Bahceciler N, Barlan I
- Issue date: 2007 Jun
Related items
Showing items related by title, author, creator and subject.
-
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.Swaminathan, Bhairavi; Thorleifsson, Guðmar; Jöud, Magnus; Ali, Mina; Johnsson, Ellinor; Ajore, Ram; Sulem, Patrick; Halvarsson, Britt-Marie; Eyjolfsson, Guðmundur; Haraldsdottir, Vilhelmina; et al. (Nature Publishing Group, 2015)Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genome-wide association study in the Nordic region identifying a novel MM risk locus at ELL2 (rs56219066T; odds ratio (OR)=1.25; P=9.6 × 10(-10)). This gene encodes a stoichiometrically limiting component of the super-elongation complex that drives secretory-specific immunoglobulin mRNA production and transcriptional regulation in plasma cells. We find that the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (P=8.6 × 10(-9) and P=6.4 × 10(-3), respectively) and, potentially, with an increased risk of bacterial meningitis (OR=1.30; P=0.0024).
-
Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy.Björnsson, Einar; Chari, Suresh; Silveira, Marina; Gossard, Andrea; Takahashi, Naoki; Smyrk, Thomas; Lindor, Keith; Landspitali The National University Hospital, Reykjavík, Iceland. Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden. (Lippincott Williams & Wilkins, 2011-05)Steroid responsive biliary strictures in patients fulfilling criteria for primary sclerosing cholangitis (PSC) have been reported. The clinical course and response to therapy in patients with PSC with elevated immunoglobulin G4 (IgG4) levels has not been investigated previously. Patients with PSC were screened for IgG4-related biliary disease during 2006 to 2008 and data were collected prospectively. A total of 33 out of 285 (12%) patients with PSC (18 males) had elevated IgG4 (>140mg/dL) with a median age of 46 years (interquartile range 29-60); 24 could be evaluated. All patients had both intrahepatic and extrahepatic biliary strictures. Pancreatic disorders were found in 4 (17%), and 11 of 24 (46%) presented with jaundice; 8 of 24 (33%) received biliary stenting for a median time of 4 months (0-6). Liver cirrhosis was diagnosed in 12 of the 24 (50%). Overall, 18 patients were treated with corticosteroids and 6 patients managed conservatively. Nine of 10 patients with elevated bilirubin had improvement. Alkaline phosphatase decreased significantly at 2 months and at last follow-up. IgG4 levels at baseline were 242 (216-357) mg/dL and decreased to 109 (80-236) at 2 months (P < 0.05) and 174 (115-269) at last follow-up (P < 0.05). A total of 39% had adverse effects of steroids, mostly hyperglycemia. Relapses occurred in 7 of the 14 (50%), but biliary stents could be removed in all. Elevated IgG4 levels were observed in 12% of typical patients with PSC. Prevalence of cirrhosis was high, suggesting a severe liver disease course. Most patients had a good biochemical response to steroids, but adverse effects were common. Future work should be directed at finding therapy that is more effective, better tolerated, and of more lasting benefit.
-
Serum immunoglobulinD in infants and childrenHaraldsson, A; Weemaes, C M; Jonasdottir, S; Olafsson, O; Van De Wiel, G; Goertz, J; Klasen, I; Department of Paediatrics, University Hospital, Reykjavík, Iceland. (Blackwell Scientific Publications, 2000-04-01)Serum immunoglobulinD (IgD) concentration is usually low in healthy individuals as compared to other immunoglobulin classes. Most studies on serum IgD are concerned with serum levels in healthy adults but reference values for young children and infants are not easily available. In order to establish age specific reference values we measured IgD levels in serum of 184 healthy Icelandic children, age 0-14 years and 60 healthy blood donors age 18-63, using the ELISA technique. Special attention was paid to the youngest age groups. Results showed low IgD values in infants and young children, gradually increasing until the age of 10 but then decreasing with age. We conclude that IgD gradually increases with age in childhood as other immunoglobulin classes but later declines. These findings can be of importance in revealing the function of IgD in the immune system as well as in the diagnosis of the hyper-IgD syndrome.